Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Compositions and methods for conjugating activatable antibodies

Compositions and methods for conjugating activatable antibodies

US Patent 11992528 · Granted May 28, 2024

Estimated economic value: $7,637,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Activatable antibodies that bind epidermal growth factor receptor and methods of2025
Methods of qualitatively and/or quantitatively analyzing properties of activatab2025
Anti-CD38 binding domains2025
Certain chemical compositions and methods of use thereof2025
Anti-CD38 antibodies2025
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Method of using an anti-epidermal growth factor receptor (EGFR) activatable anti2024
Ketone inhibitors of lysine gingipain2024
Bicyclic compounds2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024
Activatable antibodies that bind epidermal growth factor receptor and methods th2024